Fundz
A company that just raised surges hiring in 30 to 60 days. Fundz shows you the money, about a month before the job ad.See it live →

CereVasc Appoints Tony Kingsley as President and Chief Executive Officer

PRIVATESep 15, 2026•1 day ago

Position

Chief Executive Officer

Company

CereVasc

Tony Kingsley
AuburndaleBiotechnology

Description

CereVasc, Inc. has announced the appointment of Tony Kingsley as President and Chief Executive Officer, effective September 15, 2026. Dan Levangie will transition to Chairman of the Board, continuing to provide strategic guidance during this transition.

Company Information

Company

CereVasc

Location

2120 COMMONWEALTH AVE., SUITE 1

Auburndale, Massachusetts, United States

About

Located in Massachusetts’ healthcare hub, CereVasc, Inc., is a clinical stage, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Its initial product, the eShunt System, encompasses first-ever, groundbreaking percutaneous transvenous-transdural access to the central nervous system intended to allow the first minimally invasive treatment for communicating hydrocephalus (CH), a potential improvement to the current standard of care. The eShunt device concept originated from Tufts Medical Center physicians Carl Heilman, MD, Neurosurgeon-in-Chief and Chair of Neurosurgery, and Adel Malek, MD, PhD, Chief of Neurovascular Surgery and Director of Endovascular Neurosurgery. The patented eShunt System includes an endovascularly implantable cerebral spinal fluid shunt and delivery components, which are designed to treat CH without invasive surgery.

Don't miss CereVasc's next move

Get an email the moment CereVasc changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Brandon
Senior decision-maker at this company
••••••••@••••••••

See Brandon's verified email →

Tiffany
Senior decision-maker at this company
••••••••@••••••••

See Tiffany's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for CereVasc's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

CereVasc changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.